UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000018104 |
|---|---|
| Receipt number | R000020954 |
| Scientific Title | Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis |
| Date of disclosure of the study information | 2015/06/26 |
| Last modified on | 2015/06/26 17:53:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis
Acronym
Withdrawal and Dose Reduction of Pioglitazone
Scientific Title
Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis
Scientific Title:Acronym
Withdrawal and Dose Reduction of Pioglitazone
Region
| Japan |
Condition
Condition
Type 2 diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the influence of the withdrawal and dose reduction of pioglitazone
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
The change of body weight, plasma glucose, HbA1c, HDL, LDL, TG, AST, ALT after the dose reduction and withdrawal of pioglitazone
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Type 2 diabetes
Patients who underwent dose reduction and withdrawal of pioglitazone
Key exclusion criteria
Type 1 diabetes
Secondary diabetes
Target sample size
71
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hisayuki Katsuyama |
Organization
National Center for Global Health and Medicine Kohnodai Hospital
Division name
Department of Internal Medicine
Zip code
Address
1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan
TEL
+81-47-272-0034
katsuyama-hs@umin.org
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hisayuki Katsuyama |
Organization
National Center for Global Health and Medicine Kohnodai Hospital
Division name
Department of Internal Medicine
Zip code
Address
1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan
TEL
+81-47-272-0034
Homepage URL
katsuyama-hs@umin.org
Sponsor or person
Institute
National Center for Global Health and Medicine Kohnodai Hospital
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
国立国際医療研究センター国府台病院
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 06 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 09 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 09 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We enroll the patients who underwent withdrawal and dose reduction of pioglitazone and analyze the change of clinical parameters (body weight, plasma glucose, HbA1c, LDL, HDL, TG, AST, ALT, Cre) retrospectively.
Management information
Registered date
| 2015 | Year | 06 | Month | 26 | Day |
Last modified on
| 2015 | Year | 06 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020954
